We are very happy that the latest Eyetronic data of Normal Tension Glaucoma (NTG) patients could be presented with a poster at the 39th World Ophthalmology Congress (WOC) in Vancouver in August 2024.
This poster you can find in the following.
We are very happy that we were able to present Eyetronic at the 16th congress of the European Glaucoma Society (EGS) in Dublin in June 2024.
At the congress there had been a poster presentation about the latest long-term PMCF data of Normal tension glaucoma (NTG) patients beeing treated with Eyetronic.
This poster as well as some impressions about the congress you can find in the following.
We are delighted to share the news that the Eyetronic abstract with the 90-day follow-up results from Normal Tension Glaucoma (NTG) patients was accepted to be presented at the upcoming World Ophthalmology Congress (WOC), which will take place in Vancouver in August 2024.
We are excited to announce that the abstract with the latest 12-month Eyetronic data from Normal Tension Glaucoma (NTG) patients was accepted to be presented at the upcoming European Glaucoma Society (EGS) Congress in Dublin, June 01-04, 2024.
Last week our CEO, Karl Schweitzer, had the opportunity to present the Eyetronic Therapy at the LSI USA 2024 investor conference (LSI).
Following you can find the presentation given in Dana Point, California.
We are very happy that the Workshop Glaucoma from Carl Erb, MD, PhD was again very well received and we were able to be part of it.
Attached you can find our translated presentation about the Eyetronic Therapy given on this occasion.
We are very happy that we could present Eyetronic at the 10th World Glaucoma Congress (WGC) in Rome.
Please also take a look at the poster which had been presented at the WGC in Rome and shows recent data on electrical optic nerve stimulation with Eyetronic in normal tension glaucoma (NTG) patients.
In June 2023 we were able to present the Eyetronic System again at the International Congress of German Ophthalmic Surgery (DOC) in Nuremberg at the booth of our partner Polytech Domilens GmbH.
We are very happy that we were able to participate again at the Workshop Glaucoma from Carl Erb, MD, PhD.
Attached you can find the translated presentation about the Eyetronic Therapy.
In June 2022 we could present the Eyetronic System at the 34th International Congress of German Ophthalmic Surgery (DOC) in Nuremberg at the booth of our partner Polytech Domilens GmbH.
Attached you can find some pictures from the booth.
The newest data from the Eyetronic Therapy had been published in the scientific Journal Bioelectronic Medicine.
Attached you can find the publication.
We are happy that we could present the Eyetronic Therapy at the 11th annual Glaucoma 360 New Horizons Forum in San Francisco, USA at February 13th 2022.
Attached you can find a presentation about the Eyetronic Therapy in english.
We are happy that we had been a part of the 37th Workshop Glaucoma in January 2022 from Carl Erb, MD, PhD.
Attached you can find a presentation about the Eyetronic Therapy in german.
In the beginning of 2022 Neuromodtronic GmbH started its cooperation with the partner AddVision Group in the DACH region.
With the AddVision Group we have renowned partner with 200 employees on our side for the commercial activities.
For the sales part in Germany / Austria the Polytech Domilens GmbH is responsible. You can find more information on their website: www.polytech-domilens.de.
In Switzerland the distribution is done via medilas ag, whose website can be found at the following address: www.medilas.ch/de/